ViiV Healthcare

ViiV Healthcare

Interactive Data Dashboards

Track the HIV & TB response

Live indicators, province breakdowns and downloadable data.

  • Twists and turns in the race to be SA’s first widely used HIV prevention injection

    The health department has plans to roll out lenacapavir, a twice-yearly HIV prevention injection, in a select group of public sector clinics by April 2026. Meanwhile, little progress has been made towards rolling out a two-monthly prevention injection, despite the four-year head start this product had on lenacapavir. Catherine Tomlinson reports.

    ·

  • South Africa’s AIDS response: Progress, challenges, and opportunities

    Ahead of World AIDS Day 2024, Professor Salim Abdool Karim and Dr Nikita Devnarain argue that South Africa needs a concerted effort to reduce new HIV infections in young women and to prepare for the rollout of long-acting forms of HIV prevention alongside a well-functioning HIV treatment programme.

    ·

  • Why the fuss about long-acting antiretrovirals for HIV?

    HIV prevention injections that can provide two, or even six, months of protection per shot have arguably been the biggest HIV story of the year. Ahead of World AIDS Day, Professor Francois Venter assesses the state of play and the critical next steps with these potentially game-changing new tools in the fight against HIV.

    ·

  • Why we don’t have long-acting HIV treatment in South Africa

    In South Africa, taking HIV treatment means taking one or more antiretroviral tablets a day. People in some other countries have the additional option of treatment in the form of two injections administered every two months. Elri Voigt unpacks why long-acting HIV treatment is not available in South Africa and asks why the push for…

    ·

  • First HIV prevention injection approved in SA

    The South African Health Products Regulatory Authority has authorised an injection containing the antiretroviral cabotegravir for use to prevent HIV infection, according to drugmaker ViiV Healthcare. Laura Lopez Gonzalez reports.

    ·

  • Pilot projects set to inform rollout of HIV prevention shot

    South Africa is expected to begin piloting the HIV prevention injection early next year as one of several projects that experts hope will reveal the answers to some of the biggest questions about the future of the shot – who will deliver the injection, where, and how to sell people on the idea that just…

    ·

  • SA expected to begin piloting HIV prevention shot in early 2023

    South Africa is expected to begin piloting the every-other-month HIV prevention shot early next year, according to the international medicine financing initiative Unitaid. New modelling shows that the injection could prevent as many as 52 000 new HIV infections in the next two decades. But to be cost-effective in South Africa, the research argues, the…

    ·

  • More focus needed on ageing with HIV

    HIV and ageing were one of the hot topics at the recently held Conference on Retroviruses and Opportunistic Infections. Elri Voigt reports.

    ·